Treatment of adrenocortical carcinoma with o,p'-DDD.
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000328:Adult; D000856:Anorexia Nervosa / Q000139:chemically induced; D002490:Central Nervous System / Q000187:drug effects; D003967:Diarrhea / Q000139:chemically induced; D003632:Dichlorodiphenyldichloroethane / Q000009:adverse effects / Q000627:therapeutic use*; D004064:Digestive System / Q000187:drug effects; D005069:Evaluation Studies as Topic; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010211:Papilledema / Q000139:chemically induced; D011605:Psychoses, Substance-Induced / Q000139:chemically induced; D012075:Remission, Spontaneous; D013997:Time Factors; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D003632:Dichlorodiphenyldichloroethane